Urinary IL‐2 assay for monitoring intravesical bacillus Calmette‐Guérin response of superficial bladder cancer during induction course and maintenance therapy

We evaluated the clinical significance of Th1(IL‐2)/Th2(IL‐10) urinary profiles during a weekly induction course lasting 6 weeks, followed by a weekly maintenance therapy schedule for 3 weeks. Urinary IL‐2 and /IL‐10 were measured by ELISA in 39 patients receiving BCG for superficial bladder cancer...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of cancer 2003-11, Vol.107 (3), p.434-440
Hauptverfasser:	Saint, Fabien, Kurth, Nathalie, Maille, Pascale, Vordos, Dimitri, Hoznek, Andre, Soyeux, Pascale, Patard, Jean Jacques, Abbou, Claude C., Chopin, Dominique K.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Intravesical Aged Aged, 80 and over Antineoplastic agents BCG Vaccine - administration & dosage BCG Vaccine - therapeutic use Biological and medical sciences bladder neoplasm Female helper‐inducer Humans Immunotherapy Interleukin-10 - urine Interleukin-2 - urine maintenance therapy Male Medical sciences Middle Aged Mycobacterium bovis Pharmacology. Drug treatments progression Prospective Studies T lymphocyte Urinary Bladder Neoplasms - immunology Urinary Bladder Neoplasms - therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!